Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Scottish Medicines Consortium

SMC accepts Boehringer/Lilly’s Jardiance for CKD within NHS Scotland

SMC accepts Boehringer/Lilly’s Jardiance for CKD within NHS Scotland
p p Read More

The serious, progressive kidney disease affects nearly 850 million people worldwide

July 9, 2024 Boehringer Ingelheim, chronic kidney disease, EMPA-KIDNEY, empagliflozin, Jardiance, News, NHS Scotland, Scottish Medicines Consortium

AZ/Merck’s Lynparza approved by SMC to treat advanced prostate cancer in Scotland

Up to 20% of prostate cancer cases are classified as castration-resistant

March 18, 2024 astrazeneca, Lynparza, Merck & Co, metastatic castration-resistant prostate cancer, News, olaparib, Oncology, Scottish Medicines Consortium

AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland

The progressive neurological disorder affects approximately 12,400 people in Scotland

March 13, 2024 AbbVie, foslevodopa-foscarbidopa, Neurological disorders, News, Parkinson's disease, Produodopa, Scottish Medicines Consortium
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy